| Product NDC: | 16110-259 |
| Proprietary Name: | Monodox |
| Non Proprietary Name: | doxycycline |
| Active Ingredient(s): | 100 mg/1 & nbsp; doxycycline |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16110-259 |
| Labeler Name: | Aqua Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050641 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19891229 |
| Package NDC: | 16110-259-04 |
| Package Description: | 50 CAPSULE in 1 BOTTLE (16110-259-04) |
| NDC Code | 16110-259-04 |
| Proprietary Name | Monodox |
| Package Description | 50 CAPSULE in 1 BOTTLE (16110-259-04) |
| Product NDC | 16110-259 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | doxycycline |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19891229 |
| Marketing Category Name | NDA |
| Labeler Name | Aqua Pharmaceuticals, LLC |
| Substance Name | DOXYCYCLINE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |